+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transfection Technologies - Global Strategic Business Report

  • PDF Icon

    Report

  • 192 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806331

Global Transfection Technologies Market to Reach $1.8 Billion by 2030

The global market for Transfection Technologies estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$1.8 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2022-2030. Protein Production, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$633.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Therapeutic Delivery segment is readjusted to a revised 7.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $308.8 Million, While China is Forecast to Grow at 6.7% CAGR

The Transfection Technologies market in the U.S. is estimated at US$308.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$313.2 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 6.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Select Competitors (Total 38 Featured) -

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Transfection Technologies - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Transfection Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Transfection Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Transfection Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Protein Production by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Transfection Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 11: World Recent Past, Current & Future Analysis for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Therapeutic Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Bio-Medical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Bio-Medical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: World 16-Year Perspective for Bio-Medical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 18: USA Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: USA 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
  • Table 20: Canada Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: Canada Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: Canada 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 23: Japan Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: Japan Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: Japan 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: China Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: China 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 29: Europe Recent Past, Current & Future Analysis for Transfection Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Transfection Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Europe 16-Year Perspective for Transfection Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Europe 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 35: France Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: France Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: France 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Germany Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: Germany 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
  • Table 41: Italy Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: Italy Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: Italy 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 44: UK Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: UK Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: UK 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • Table 47: Rest of Europe Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Rest of Europe Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Rest of Europe 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Transfection Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Asia-Pacific Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Asia-Pacific 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
  • Table 53: Rest of World Recent Past, Current & Future Analysis for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: Rest of World Historic Review for Transfection Technologies by Application - Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: Rest of World 16-Year Perspective for Transfection Technologies by Application - Percentage Breakdown of Value Sales for Protein Production, Therapeutic Delivery, Bio-Medical Research and Other Applications for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

Table Information